Related Experiment Videos

Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice

J Yother, J E Volanakis, D E Briles

Journal of Immunology (Baltimore, Md. : 1950)

|May 1, 1982

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pneumococcal Vaccines.

Microbiology spectrum·2019

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.

Mucosal immunology·2015

Asthma and antibodies to pneumococcal virulence proteins.

Infection·2013

Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.

Vaccine·2008

Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

Infection and immunity·2007

Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.

Clinical and experimental immunology·2006

See all related articles